Summary
Passage of the cardioselective beta adrenoceptor antagonists atenolol and metoprolol from serum to breast milk was assessed in 7 lactating women treated with atenolol due to hypertension developing during pregnancy, and in 3 healthy women who agreed to take metoprolol at cessation of lactation. For both drugs, the concentration in breast milk was higher than that in serum at every time studied, and the resulting AUC values were 1.5–6.8 times (atenolol) and 2.6–3.7 times (metoprolol) greater in milk than in serum. Assuming ingestion of 75 ml milk per meal, and as the maximum milk concentrations recorded were 6.35 µmol/l (atenolol) and 2.58 µmol/l (metoprolol), the data indicate that the dose following a meal at the time of maximum maternal drug concentration would not exceed 0.13 mg atenolol and 0.05 mg metoprolol, and would be considerably less after the other meals. In the only infant from whom serum samples could be obtained, the plasma atenolol concentration ranged between 0 and 0.26 µmol/l. None of the atenolol-exposed infants had any sign of an effect of the beta blocker. It would seem likely that, unless renal (atenolol) or hepatic (metoprolol) function in the infant were pronouncedly impaired, breast feeding need not be interrupted due to maternal medication with ordinary doses of either of these drugs. However, the infants should be observed for signs of beta blockade.
References
Melander A, Niklasson B, Ingemarsson I, Liedholm H, Scherstén B, Sjöberg NO (1978) Transplacental passage of atenolol in man. Eur J Clin Pharmacol 14: 93–94
Sandström B (1978) Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecol Obstet Invest 9: 195–204
Ervik M (1975) Quantitative determination of metoprolol in plasma and urine by gas chromatography. Acta Pharmacol Toxicol 36: (Suppl V) 136–144
Yee Y-G, Rubin P, Blaschke TF (1979) Atenolol determination by high-performance liquid chromatography and fluorescence detection. J Chromatogr 171: 357–362
Wilson JT, Brown RD, Cherek DR, Dailey JW, Hilman B, Jobe PC, Manno BR, Redetzki HM, Stewart JJ (1980) Drug excretion in human breast milk: Principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 5: 1–66
Karlberg B, Lundberg D, Åberg H (1974) Excretion of propranolol in human breast milk. Acta Pharmacol Toxicol 34: 222–224
Sandström B, Regårdh C-G (1980) Metoprolol excretion into breast milk. Br J Clin Pharmacol 9: 518–519
Melander A, Danielson K, Scherstén B, Wåhlin E (1977) Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther 22: 108–112
Melander A, Stenberg P, Liedholm H, Scherstén B, Wåhlin-Boll E (1979) Food-induced reduction in bioavailability of atenolol. Eur J Clin Pharmacol 16: 327–330
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liedholm, H., Melander, A., Bitzén, P.O. et al. Accumulation of atenolol and metoprolol in human breast milk. Eur J Clin Pharmacol 20, 229–231 (1981). https://doi.org/10.1007/BF00544603
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544603